Public Sector Pension Investment Board (PSP Investments)’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.6M Sell
45,832
-6,205
-12% -$4.22M 0.07% 200
2026
Q1
$40.2M Buy
52,037
+39,285
+308% +$30.1M 0.13% 106
2025
Q4
$9.84M Buy
12,752
+4,373
+52% +$2.97M 0.03% 497
2025
Q3
$4.71M Buy
8,379
+788
+10% +$446K 0.02% 815
2025
Q2
$3.99M Sell
7,591
-6,464
-46% -$3.61M 0.02% 783
2025
Q1
$8.91M Buy
14,055
+1,217
+9% +$837K 0.04% 433
2024
Q4
$9.14M Buy
12,838
+8,497
+196% +$7.13M 0.04% 359
2024
Q3
$4.56M Buy
4,341
+500
+13% +$556K 0.02% 525
2024
Q2
$4.04M Buy
3,841
+1,679
+78% +$1.63M 0.03% 524
2024
Q1
$2.08M Sell
2,162
-282
-12% -$268K 0.01% 750
2023
Q4
$2.15M Sell
2,444
-8,990
-79% -$7.4M 0.02% 736
2023
Q3
$9.41M Buy
11,434
+1,103
+11% +$867K 0.07% 196
2023
Q2
$7.42M Sell
10,331
-1,497
-13% -$1.15M 0.05% 271
2023
Q1
$9.72M Sell
11,828
-1,504
-11% -$1.13M 0.07% 205
2022
Q4
$9.62M Buy
13,332
+1,842
+16% +$1.36M 0.07% 210
2022
Q3
$7.92M Buy
11,490
+1,099
+11% +$692K 0.07% 222
2022
Q2
$6.14M Sell
10,391
-4,582
-31% -$2.98M 0.05% 269
2022
Q1
$10.5M Sell
14,973
-2,670
-15% -$1.69M 0.06% 227
2021
Q4
$11.1M Sell
17,643
-80
-0.5% -$49.2K 0.06% 239
2021
Q3
$10.7M Buy
17,723
+1,310
+8% +$813K 0.06% 265
2021
Q2
$9.17M Buy
16,413
+6,460
+65% +$3.27M 0.06% 289
2021
Q1
$4.71M Buy
9,953
+1,710
+21% +$833K 0.03% 528
2020
Q4
$3.98M Sell
8,243
-4,390
-35% -$2.37M 0.03% 559
2020
Q3
$7.07M Buy
12,633
+2,870
+29% +$1.74M 0.06% 296
2020
Q2
$6.09M Buy
9,763
+1,800
+23% +$1.02M 0.06% 302
2020
Q1
$3.89M Sell
7,963
-32,150
-80% -$13.3M 0.05% 368
2019
Q4
$15.1M Buy
40,113
+1,324
+3% +$445K 0.09% 211
2019
Q3
$10.8M Buy
38,789
+5,241
+16% +$1.55M 0.07% 237
2019
Q2
$10.5M Buy
33,548
+3,700
+12% +$1.23M 0.08% 207
2019
Q1
$12.3M Buy
29,848
+25,866
+650% +$10.7M 0.11% 159
2018
Q4
$1.49M Buy
3,982
+300
+8% +$110K 0.01% 736
2018
Q3
$1.49M Sell
3,682
-700
-16% -$266K 0.01% 768
2018
Q2
$1.51M Hold
4,382
0.01% 579
2018
Q1
$1.51M Buy
4,382
+200
+5% +$69.6K 0.01% 539
2017
Q4
$1.57M Buy
4,182
+200
+5% +$81K 0.01% 615
2017
Q3
$1.78M Sell
3,982
-4,615
-54% -$2.2M 0.01% 521
2017
Q2
$4.22M Sell
8,597
-8,800
-51% -$3.85M 0.04% 339
2017
Q1
$6.74M Buy
17,397
+700
+4% +$259K 0.06% 316
2016
Q4
$6.13M Sell
16,697
-200
-1% -$76.1K 0.06% 318
2016
Q3
$6.79M Buy
16,897
+2,100
+14% +$842K 0.07% 279
2016
Q2
$5.17M Buy
14,797
+2,100
+17% +$809K 0.06% 288
2016
Q1
$4.58M Sell
12,697
-7,100
-36% -$2.93M 0.05% 271
2015
Q4
$10.7M Sell
19,797
-600
-3% -$325K 0.09% 196
2015
Q3
$9.49M Sell
20,397
-5,600
-22% -$3.01M 0.08% 207
2015
Q2
$13.3M Buy
25,997
+400
+2% +$195K 0.1% 213
2015
Q1
$11.6M Buy
25,597
+436
+2% +$185K 0.09% 221
2014
Q4
$10.3M Sell
25,161
-2,000
-7% -$787K 0.07% 246
2014
Q3
$9.79M Sell
27,161
-2,800
-9% -$938K 0.06% 265
2014
Q2
$8.46M Buy
29,961
+1,161
+4% +$344K 0.05% 313
2014
Q1
$8.65M Sell
28,800
-400
-1% -$123K 0.06% 283
2013
Q4
$8.04M Buy
29,200
+3,200
+12% +$920K 0.05% 310
2013
Q3
$8.13M Sell
26,000
-200
-0.8% -$52.6K 0.05% 267
2013
Q2
$5.89M Buy
+26,200
New +$6.1M 0.05% 314

Other funds holding REGN

Public Sector Pension Investment Board (PSP Investments)'s REGN Position: Q2 2026 in Review

Public Sector Pension Investment Board (PSP Investments) reduced its Regeneron Pharmaceuticals (REGN) stake by 12% in Q2 2026, selling an estimated $4.22M and leaving 45,832 shares worth $28.6M. The position accounts for 0.07% of the portfolio, ranked #200.

Public Sector Pension Investment Board (PSP Investments) first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $40.2M in Q1 2026. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Public Sector Pension Investment Board (PSP Investments) held 45,832 shares of Regeneron Pharmaceuticals worth $28.6M as of Q2 2026.
  • Public Sector Pension Investment Board (PSP Investments) sold 6,205 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $4.22M.
  • Regeneron Pharmaceuticals made up 0.07% of Public Sector Pension Investment Board (PSP Investments)'s portfolio in Q2 2026, its #200 holding.
  • Public Sector Pension Investment Board (PSP Investments) first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • Public Sector Pension Investment Board (PSP Investments)'s Regeneron Pharmaceuticals position peaked at $40.2M in Q1 2026.
  • 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Public Sector Pension Investment Board (PSP Investments)'s 13F filing for Q2 2026, filed 13 Aug 2026.